Sat 8/15/2020 16:45 ET
DJIA27931.0233.520.12%TELCO173.360.640.37%GOLD1944.270.390.02%Shanghai3315.455.300.16%
S&P 5003372.850.670.02%BANKS356.282.030.57%OIL42.010.230.55%BITCOIN11879.49109.290.92%
NASDAQ11019.3023.140.21%PHARM629.690.440.07%US/EU1.180.000.24%Futures3363.752.350.07%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit (SOLITON - SOLY)    Stock Due Diligence for All

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add SOLY
  
From: pedley (Rep: 36)Date: 04/02/2020 13:09
Forum: Wall Street Pit - Msg #2831107 - List SOLY msgs Thread #674139615 (Rec: 0)
Back to double digits on results: Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced the results from its pivotal cellulite trial will be now be presented at the AAD 2020 Annual Meeting, to now be held virtually in the next 6-8 weeks.

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser pedley: Reward | Watch | IgnoreSOLY: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add SOLY
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 2020- TheLion.com, Inc.